Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 149

    1.

    Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

    Wong D, Campbell I, Groenwald C, Lancaster E.

    Br J Ophthalmol. 2004 Apr;88(4):598; author reply 598. No abstract available. PMID: 15031200 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration.

    Jonas JB, Kreissig I, Degenring R.

    Graefes Arch Clin Exp Ophthalmol. 2002 Oct;240(10):873-4. No abstract available. PMID: 12530461 [PubMed - indexed for MEDLINE]Related articles

    3.

    Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.

    Jonas JB, Spandau UH, Harder B, Vossmerbaeumer U, Kamppeter BA.

    Am J Ophthalmol. 2005 Jun;139(6):1073-9.PMID: 15953439 [PubMed - indexed for MEDLINE]Related articles

    4.

    Triamcinolone for occult exudative age-related macular degeneration.

    Gillies MC, Simpson JM, Zhu M.

    Am J Ophthalmol. 2006 Jan;141(1):228; author reply 228-9. No abstract available. PMID: 16387021 [PubMed - indexed for MEDLINE]Related articles

    5.

    The temporal sequence of combined intravitreal triamcinolone acetonide and photodynamic therapy for exudative age-related macular degeneration.

    Roth DB, Kulkarni KM, Feuer WJ.

    Ophthalmic Surg Lasers Imaging. 2008 Jan-Feb;39(1):12-6.PMID: 18254345 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.

    Jonas JB.

    Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. Review.PMID: 16396641 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intravitreal triamcinolone acetonide for exudative age-related macular degeneration among Japanese patients.

    Ito M, Okubo A, Sonoda Y, Yamakiri K, Sakamoto T.

    Ophthalmologica. 2006;220(2):118-24.PMID: 16491035 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration.

    Penfold PL, Wong JG, Gyory J, Billson FA.

    Clin Experiment Ophthalmol. 2001 Jun;29(3):188-92.PMID: 11446466 [PubMed - indexed for MEDLINE]Related articles

    10.

    Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration.

    Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B.

    Ophthalmic Res. 2006;38(6):324-8. Epub 2006 Oct 13.PMID: 17047404 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cataract surgery combined with intravitreal injection of triamcinolone acetonide.

    Jonas JB, Kreissig I, Budde WM, Degenring RF.

    Eur J Ophthalmol. 2005 May-Jun;15(3):329-35.PMID: 15945000 [PubMed - indexed for MEDLINE]Related articles

    12.

    Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.

    Ergun E, Maár N, Ansari-Shahrezaei S, Wimpissinger B, Krepler K, Wedrich A, Stur M.

    Am J Ophthalmol. 2006 Jul;142(1):10-16.PMID: 16815246 [PubMed - indexed for MEDLINE]Related articles

    13.

    Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration.

    Gopal L, Sharma T.

    Indian J Ophthalmol. 2007 Nov-Dec;55(6):431-5. Review.PMID: 17951899 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    [Considerations about intravitreal triamcinolone use]

    Gómez-Ulla F, López Gálvez MI.

    Arch Soc Esp Oftalmol. 2007 Jun;82(6):327-9. Spanish. No abstract available. PMID: 17573639 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.

    Lee J, Freeman WR, Azen SP, Chung EJ, Koh HJ.

    Retina. 2007 Nov-Dec;27(9):1205-13.PMID: 18046226 [PubMed - indexed for MEDLINE]Related articles

    16.

    Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.

    Ruiz-Moreno JM, Montero JA, Barile S, Zarbin MA.

    Retina. 2006 Jul-Aug;26(6):602-12.PMID: 16829800 [PubMed - indexed for MEDLINE]Related articles

    17.

    Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.

    Jonas JB, Kreissig I, Spandau UH, Harder B.

    Am J Ophthalmol. 2006 Mar;141(3):579-80.PMID: 16490517 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice.

    Dubey AK.

    Indian J Ophthalmol. 2006 Dec;54(4):290; author reply 290-1. No abstract available. PMID: 17090895 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    [Intravitreal triamcinolone therapy. New therapeutic alternative for patients with vision-threatening eye diseases]

    Klitgaard TL, Haamann PH, Villumsen JE, Larsen M.

    Ugeskr Laeger. 2005 Apr 18;167(16):1729-31. Danish. No abstract available. PMID: 15898599 [PubMed - indexed for MEDLINE]Related articles

    20.

    Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.

    Lorenzo Carrero J, Pérez Flores I, González Barcia M.

    Am J Ophthalmol. 2006 Sep;142(3):529; author reply 529-30. No abstract available. PMID: 16935616 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Recent activity

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...